MIYA CHIPKA: Open Payments
NPI 1174244321 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 38 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $330 |
| ABBVIE INC. | 9 | $240 |
| Lilly USA, LLC | 6 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $189 |
| Regeneron Healthcare Solutions, Inc. | 2 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $53 |
| Celltrion USA Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $20 |
| QOL Medical, LLC | 1 | $16 |
Products named: TREMFYA, OMVOH, RINVOQ, DUPIXENT, ENTYVIO, GATTEX, XIFAXAN, SKYRIZI.
Industry payments across IN — which companies pay providers there.
